Expression of hypoxia-inducible factors is correlated with the presence of a fibrotic focus and angiogenesis in pancreatic ductal adenocarcinomas

Histopathology

Volumn 46, Issue 6, 2005, Pages 668-676

  Couvelard, Anne ^a   O'Toole, D ^a   Leek, R ^b   Turley, H ^b   Sauvanet, A ^a   Degott, C ^a   Ruszniewski, P ^a   Belghiti, J ^a   Harris, A L ^b   Gatter, K ^b   Pezzella, F ^b  

^a BEAUJON HOSPITAL   (France)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Adenocarcinomas; Angiogenesis; Fibrotic focus; HIF; Hypoxia; Pancreas

Indexed keywords

CARBONATE DEHYDRATASE; CARBONATE DEHYDRATASE IX; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 2ALPHA; UNCLASSIFIED DRUG; VASCULOTROPIN;

ADULT; AGED; ANGIOGENESIS; ARTICLE; CANCER SURVIVAL; CLINICAL ARTICLE; FEMALE; FIBROSIS; HUMAN; HUMAN TISSUE; HYPOXIA; IMMUNOHISTOCHEMISTRY; MALE; MICROVASCULATURE; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; TUMOR NECROSIS;

ADULT; AGED; ANOXIA; ANTIGENS, NEOPLASM; CARBONIC ANHYDRASES; CARCINOMA, PANCREATIC DUCTAL; FEMALE; FIBROSIS; FOLLOW-UP STUDIES; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NECROSIS; NEOPLASM STAGING; NEOVASCULARIZATION, PATHOLOGIC; PANCREAS; PANCREATIC NEOPLASMS; SURVIVAL ANALYSIS; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 20644470124     PISSN: 03090167     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2005.02160.x     Document Type: Article

References (48)

1. Brizel DM, Scully SP, Harrelson JM et al. Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma. Cancer Res. 1996; 56; 941-943.
2. Hockel M, Schlenger K, Aral B, Mitze M, Schaffer U, Vaupel P. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res. 1996; 56; 4509-4515.
3. Wykoff CC, Pugh CW, Harris AL, Maxwell PH, Ratcliffe PJ. The HIF pathway: implications for patterns of gene expression in cancer. Novartis Found. Symp. 2001; 240; 212-225; discussion 225-231.
4. Zhong H, De Marzo AM, Laughner E et al. Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases. Cancer Res. 1999; 59; 5830-5835.
5. Talks KL, Turley H, Gatter KC et al. The expression and distribution of the hypoxia-inducible factors HIF-1alpha and HIF-2alpha in normal human tissues, cancers, and tumor-associated macrophages. Am. J. Pathol. 2000; 157; 411-121.
6. Wykoff CC, Beasley NJ, Watson PH et al Hypoxia-inducible expression of tumor-associated carbonic anhydrases. Cancer Res. 2000; 60; 7075-7083.
7. Pugh CW, Ratcliffe PJ. Regulation of angiogenesis by hypoxia: role of the HIF system. Nat. Med. 2003; 9; 677-684.
8. Landis SH, Murray T, Bolden S, Wingo PA. Cancer statistics, 1998. CA Cancer J. Clin. 1998; 48; 6-29.
9. Rosewicz S, Wiedenmann B. Pancreatic carcinoma. Lancet 1997; 349; 485-489.
10. Karademir S, Sokmen S, Terzi C et al. Tumor angiogenesis as a prognostic predictor in pancreatic cancer. J. Hepatobiliary Pancreat. Surg. 2000; 7; 489-195.
11. Khan AW, Dhillon AP, Hutchins R et al. Prognostic significance of intratumoural microvessel density (IMD) in resected pancreatic and ampullary cancers to standard histopathological variables and survival. Eur. J. Surg. Oncol. 2002; 28; 637-644.
12. Ueda T, Oda T, Kinoshita T et al. Neovascularization in pancreatic ductal adenocarcinoma: microvessel count analysis, comparison with non-cancerous regions and other types of carcinomas. Oncol. Rep. 2002; 9; 239-245.
13. Seo Y, Baba H, Fukuda T, Takashima M, Sugimachi K. High expression of vascular endothelial growth factor is associated with liver metastasis and a poor prognosis for patients with ductal pancreatic adenocarcinoma. Cancer 2000; 88; 2239-2245.
14. Kitada T, Seki S, Sakaguchi H, Sawada T, Hirakawa K, Wakasa K. Clinicopathological significance of hypoxia-inducible factor-lalpha expression in human pancreatic carcinoma. Histopathology 2003; 43; 550-555.
15. Hansel DE, Rahman A, Hermans J et al. Liver metastases arising from well-differentiated pancreatic endocrine neoplasms demonstrate increased VEGF-C expression. Mod. Pathol. 2003; 16; 652-659.
16. Sipos B, Weber D, Ungefroren H et al. Vascular endothelial growth factor mediated angiogenic potential of pancreatic ductal carcinomas enhanced by hypoxia: an in vivo and in vitro study. Int. J. Cancer 2002; 102; 592-600.
17. Luttges J, Schemm S, Vogel I, Hedderich J, Kremer B, Klöppel G. The grade of pancreatic ductal carcinomas is an independent prognostic factor and is superior to the immunohistochemical assessment of proliferation. J. Pathol 2000; 191; 154-161.
18. Merkel S, Mansmann U, Meyer T, Papadopoulos T, Hohenberger W, Hermanek P. Confusion by frequent changes in staging of exocrine pancreatic carcinoma. Pancreas 2004; 29; 171-178.
19. Sobin LH, Wittekind C eds. TNM classification of malignant tumors, 6th edn. New York: John Wiley & Sons, 2002.
20. Turley H, Scott PA, Watts VM, Bicknell R, Harris AL, Gatter KC. Expression of VEGF in routinely fixed material using a new monoclonal antibody VG1. J. Pathol. 1998; 186; 313-318.
21. Wykoff CC, Beasley N, Watson PH et al. Expression of the hypoxia-inducible and tumor-associated carbonic anhydrases in ductal carcinoma in situ of the breast. Am. J. Pathol. 2001; 158; 1011-1019.
22. Hui EP, Chan AT, Pezzella F et al. Coexpression of hypoxia-inducible factors 1alpha and 2alpha. carbonic anhydrase IX, and vascular endothelial growth factor in nasopharyngeal carcinoma and relationship to survival. Clin. Cancer Res. 2002; 8; 2595-2604.
23. Leek RD, Landers RJ, Harris AL, Lewis CE. Necrosis correlates with high vascular density and focal macrophage infiltration in invasive carcinoma of the breast. Br. J. Cancer 1999; 79; 991-995.
24. Hasebe T, Tsuda H, Hirohashi S et al Fibrotic focus in infiltrating ductal carcinoma of the breast: a significant histopathological prognostic parameter for predicting the long-term survival of the patients. Breast Cancer Res. Treat. 1998; 49; 195-208.
25. Watanabe I, Hasebe T, Sasaki S et al. Advanced pancreatic ductal cancer: fibrotic focus and beta-catenin expression correlate with outcome. Pancreas 2003; 26; 326-333.
26. Vaupel P, Hoeckel M. Predictive power of the tumor oxygenation status. Adv. Exp. Med. Biol 1999; 471; 533-539.
27. Harris AL. Hypoxia - a key regulatory factor in tumour growth. Nat. Rev. Cancer 2002; 2; 38-17.
28. Colpaert C, Vermeulen P, van Beest P et al. Intratumoral hypoxia resulting in the presence of a fibrotic focus is an independent predictor of early distant relapse in lymph node-negative breast cancer patients. Histopathology 2001; 39; 416-125.
29. Hasebe T, Tsuda H, Hirohashi S et al. Fibrotic focus in invasive ductal carcinoma: an indicator of high tumor aggressiveness. Jpn J. Cancer Res. 1996; 87; 385-394.
30. Hasebe T, Sasaki S, Imoto S, Mukai K, Yokose T, Ochiai A. Prognostic significance of fibrotic focus in invasive ductal carcinoma of the breast: a prospective observational study. Mod. Pathol. 2002; 15; 502-516.
31. Colpaert C, Vermeulen P, Jeuris W et al. Early distant relapse in 'node-negative' breast cancer patients is not predicted by occult axillary lymph node metastases, but by the features of the primary tumour. J. Pathol. 2001; 193; 442-149.
32. Nishimura R, Hasebe T, Tsubono Y et al. The fibrotic focus in advanced colorectal carcinoma: a hitherto unrecognized histological predictor for liver metastasis. Virchows Arch. 1998; 433; 517-522.
33. Buchler P, Reber HA, Buchler M et al. Hypoxia-inducible factor 1 regulates vascular endothelial growth factor expression in human pancreatic cancer. Pancreas 2003; 26; 56-64.
34. Jitsuiki Y, Hasebe T, Tsuda H et al. Optimizing microvessel counts according to tumor zone in invasive ductal carcinoma of the breast. Mod. Pathol. 1999; 12; 492-498.
35. Niedergethmann M, Hildenbrand R, Wostbrock B et al. High expression of vascular endothelial growth factor predicts early recurrence and poor prognosis after curative resection for ductal adenocarcinoma of the pancreas. Pancreas 2002; 25; 122-129.
36. Itakura J, Ishiwata T, Friess H et al. Enhanced expression of vascular endothelial growth factor in human pancreatic cancer correlates with local disease progression. Clin. Cancer Res. 1997; 3; 1309-1316.
37. Beasley NJ, Wykoff CC, Watson PH et al. Carbonic anhydrase IX. an endogenous hypoxia marker, expression in head and neck squamous cell carcinoma and its relationship to hypoxia, necrosis, and microvessel density. Cancer Res. 2001; 61; 5262-5267.
38. Lancaster JA, Harris AL, Davidson SE et al. Carbonic anhydrase (CA IX) expression, a potential new intrinsic marker of hypoxia: correlations with tumor oxygen measurements and prognosis in locally advanced carcinoma of the cervix. Cancer Res. 2001; 61; 6394-6399.
39. Colpaert CG, Vermeulen PB, Fox SB, Harris AL, Dirix LY, Van Marck EA. The presence of a fibrotic focus in invasive breast carcinoma correlates with the expression of carbonic anhydrase IX and is a marker of hypoxia and poor prognosis. Breast Cancer Res. Treat. 2003; 81; 137-147.
40. Chia SK, Wykoff CC, Watson PH et al. Prognostic significance of a novel hypoxia-regulated marker, carbonic anhydrase IX, in invasive breast carcinoma. J. Clin. Oncol. 2001; 19; 3660-3668.
41. Giatromanolaki A, Koukourakis MI, Sivridis E et al. Expression of hypoxia-inducible carbonic anhydrase-9 relates to angiogenic pathways and independently to poor outcome in non-small cell lung cancer. Cancer Res. 2001; 61; 7992-7998.
42. Birner P, Schindl M, Obermair A, Plank C, Breitenecker G, Oberhuber G. Overexpression of hypoxia-inducible factor 1alpha is a marker for an unfavorable prognosis in early-stage invasive cervical cancer. Cancer Res. 2000; 60; 4693-1696.
43. Birner P, Schindl M, Obermair A, Breitenecker G, Oberhuber G. Expression of hypoxia-inducible factor 1alpha in epithelial ovarian tumors: its impact on prognosis and on response to chemotherapy. Clin. Cancer Res. 2001; 7; 1661-1668.
44. Birner P, Gatterbauer B, Oberhuber G et al. Expression of hypoxia-inducible factor-1 alpha in oligodendrogliomas: its impact on prognosis and on neoangiogenesis. Cancer 2001; 92; 165-171.
45. Volm M, Koomagi R. Hypoxia-inducible factor (HIF-1) and its relationship to apoptosis and proliferation in lung cancer. Anticancer Res. 2000; 20; 1527-1533.
46. Maxwell PH, Dachs GU, Gleadle JM et al. Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth. Proc. Natl Acad. Sci. USA 1997; 94; 8104-8109.
47. An WG, Kanekal M, Simon MC, Maltepe E, Blagosklonny MV, Neckers LM. Stabilization of wild-type p53 by hypoxia-inducible factor 1alpha. Nature 1998; 392; 405-408.
48. Leek RD, Talks KL, Pezzella F et al. Relation of hypoxia-inducible factor-2 alpha (HIF-2 alpha) expression in tumor-infiltrative macrophages to tumor angiogenesis and the oxidative thymidine phosphorylase pathway in human breast cancer. Cancer Res. 2002; 62; 1326-1329.